Advertisement

Postoperative Adhesion Development Following Cesarean and Open Intra-Abdominal Gynecological Operations

A Review

Abstract

In this review, we discuss the pathophysiology of adhesion development, the impact of physiological changes associated with pregnancy on markers of adhesion development, and the clinical implications of adhesion development following cesarean delivery (CD). Although peritoneal adhesions develop after the overwhelming majority of intra-abdominal and pelvic surgery, there is evidence in the literature that suggests that patients having CD may develop adhesions less frequently. However, adhesions continue to be a concern after CD, and are likely significant, albeit on average less than after gynecological operations, but with potential to cause significant delay in the delivery of the baby with serious, lifelong consequences. Appreciation of the pathophysiology of adhesion development described herein should allow a more informed approach to the rapidly evolving field of intra-abdominal adhesions and should serve as a reference for an evidence-based approach to consideration for the prevention and treatment of adhesions.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 510

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Swolin K.50 fertility operations. I. Literature and methods. Acta Obstet Gynecol Scand. 1967;46(2):234-250.

  2. 2.

    Winston RM. Microsurgery of the fallopian tube: from fantasy to reality. Fertil Steril. 1980;34(6):521-530.

  3. 3.

    Vrijland WW, Jeekel J, van Geldorp HJ, Swank DJ, Bonjer HJ. Abdominal adhesions: intestinal obstruction, pain, and infertility. Surg Endosc. 2003;17(7):1017-1022.

  4. 4.

    Marana R, Catalano GF, Muzii L. Salpingoscopy. Curr Opin Obstet Gynecol. 2003;15(4):333-336.

  5. 5.

    Duffy DM, diZerega GS. Adhesion controversies: pelvic pain as a cause of adhesions, crystalloids in preventing them. J Reprod Med. 1996;41(1):19-26.

  6. 6.

    Barmparas G, Branco BC, Schnuriger B, Lam L, Inaba K, Demetriades D. The incidence and risk factors of post-laparotomy adhesive small bowel obstruction. J Gastrointest Surg. 2010;14(10):1619-1628.

  7. 7.

    Holmdahl L, Risberg B. Adhesions: prevention and complications in general surgery. Eur J Surg. 1997;163(3):169-174.

  8. 8.

    Potter KL, Held-Warmkessel J. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations. Clin J Oncol Nurs. 2008;12(2):265-271.

  9. 9.

    Diamond MP. Incidence of postsurgical adhesions. In: GS diZerega, ed. Peritoneal Surgery. New York, NY: Spriger-Verlag; 2000:217-220.

  10. 10.

    Diamond MP. Surgical aspects of infertility. In: J S, ed. Gynecology and obstetrics. Vol 2. Philadelphia, PA: Harper & Row; 1988:1-23.

  11. 11.

    Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril. 1996;66(6):904-910.

  12. 12.

    Morales KJ, Gordon MC, Bates GW, Jr. Postcesarean delivery adhesions associated with delayed delivery of infant. Am J Obstet Gynecol. 2007;196(5):461.e461-e466.

  13. 13.

    Tulandi T, Agdi M, Zarei A, Miner L, Sikirica V. Adhesion development and morbidity after repeat cesarean delivery. Am J Obstet Gynecol. 2009;201(1):56.e51-e56.

  14. 14.

    Fushiki HIT, Kobayashi H, Yoshimoto H. Efficacy of Seprafilm as an adhesion prevention barrier in cesarean sections. Obstet Gynecol Treat. 2005;91:557-561.

  15. 15.

    Al-Took S, Platt R, Tulandi T. Adhesion-related small-bowel obstruction after gynecologic operations. Am J Obstet Gynecol. 1999;180(2 Pt 1):313-315.

  16. 16.

    Tollanes MC, Melve KK, Irgens LM, Skjaerven R. Reduced fertility after cesarean delivery: a maternal choice. Obstet Gynecol. 2007;110(6):1256-1263.

  17. 17.

    Bhattacharya S, Porter M, Harrild K, et al. Absence of conception after caesarean section: voluntary or involuntary? BJOG. 2006; 113(3):268-275.

  18. 18.

    Kendrick JS, Tierney EF, Lawson HW, Strauss LT, Klein L, Atrash HK. Previous cesarean delivery and the risk of ectopic pregnancy. Obstet Gynecol. 1996;87(2):297-301.

  19. 19.

    Stark M, Hoyme UB, Stubert B, Kieback D, di Renzo GC. Postcesarean adhesions—are they a unique entity? J Matern Fetal Neonatal Med. 2008;21(8):513-516.

  20. 20.

    Dunn RC, Buttram VC, Jr. Tissue-type plasminogen activator as an adjuvant for post surgical adhesions. Prog Clin Biol Res. 1990; 358:113-118.

  21. 21.

    Saed GM, Diamond MP. Molecular characterization of postoperative adhesions: the adhesion phenotype. J Am Assoc Gynecol Laparosc. 2004;11(3):307-314.

  22. 22.

    Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718-727.

  23. 23.

    Saed GM, Diamond MP. Hypoxia-induced irreversible upregulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertil Steril. 2002;78(1):144-147.

  24. 24.

    Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl. 1997(577): 17-23.

  25. 25.

    Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-beta and TNF-alpha. Am J Physiol. 1992;263(4 Pt 1):L487-L494.

  26. 26.

    Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril. 2005;83(2):405-409.

  27. 27.

    Saed GM, Diamond MP. Differential expression of alpha smooth muscle cell actin in human fibroblasts isolated from intraperitoneal adhesions and normal peritoneal tissues. Fertil Steril. 2004;(suppl 3):1188-1192.

  28. 28.

    Saed GM, Zhang W, Chegini N, Holmdahl L, Diamond MP. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen. 1999;7(6):504-510.

  29. 29.

    Saed GM, Diamond MP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril. 2003;79(1):164-168.

  30. 30.

    Saed GM, Zhang W, Diamond MP. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril. 2001;75(4):763-768.

  31. 31.

    Saed GM, Munkarah AR, Diamond MP. Cyclooxygenase-2 is expressed in human fibroblasts isolated from intraperitoneal adhesions but not from normal peritoneal tissues. Fertil Steril. 2003;79(6):1404-1408.

  32. 32.

    Ivarsson ML, Holmdahl L, Falk P, Molne J, Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest. 1998;58(3):195-203.

  33. 33.

    Shavell VI, Saed GM, Diamond MP. Review: cellular metabolism: contribution to postoperative adhesion development. Reprod Sci. 2009;16(7):627-634.

  34. 34.

    Cookson VJ, Chapman NR. NF-kappaB function in the human myometrium during pregnancy and parturition. Histol Histopathol. 2010;25(7):945-956.

  35. 35.

    Shukla A, Rasik AM, Shankar R. Nitric oxide inhibits wounds collagen synthesis. Mol Cell Biochem. 1999;200(l-2):27-33.

  36. 36.

    Ferrini MG, Vernet D, Magee TR, et al. Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide. 2002;6(3):283-294.

  37. 37.

    Jiang ZL, Zhu X, Diamond MP, Abu-Soud HM, Saed GM. Nitric oxide synthase isoforms expression in fibroblasts isolated from human normal peritoneum and adhesion tissues. Fertil Steril. 2008;90(3):769-774.

  38. 38.

    Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84.

  39. 39.

    Terada LS, Guidot DM, Leff JA, et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci U S A. 1992;89(8):3362-3366.

  40. 40.

    Yamamoto Y, Konig P, Henrich M, Dedio J, Kummer W. Hypoxia induces production of nitric oxide and reactive oxygen species in glomus cells of rat carotid body. Cell Tissue Res. 2006;325(1):3-11.

  41. 41.

    Zhu H, Bunn HF. Oxygen sensing and signaling: impact on the regulation of physiologically important genes. Respir Physiol. 1999;115(2):239-247.

  42. 42.

    Kettle AJ, van Dalen CJ, Winterbourn CC. Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration. Redox Rep. 1997;3(5-6):257-258.

  43. 43.

    Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982;70(3):598-607.

  44. 44.

    Tahboub YR, Galijasevic S, Diamond MP, Abu-Soud HM. Thiocyanate modulates the catalytic activity of mammalian peroxidases. J Biol Chem. 2005;280(28):26129-26136.

  45. 45.

    Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82(1):47-95.

  46. 46.

    Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993;21(4):433-441.

  47. 47.

    Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Ann Rev Biochem. 1993;62:797-821.

  48. 48.

    Reed KL, Heydrick SJ, Aarons CB, et al. A neurokinin-1 receptor antagonist that reduces intra-abdominal adhesion formation decreases oxidative stress in the peritoneum. Am J Physiol Gastrointest Liver Physiol. 2007;293(3):G544-G551.

  49. 49.

    Heydrick SJ, Reed KL, Cohen PA, et al. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res. 2007;143(2):311-319.

  50. 50.

    Reed KL, Stucchi AF, Leeman SE, Becker JM. Inhibitory effects of a neurokinin-1 receptor antagonist on postoperative peritoneal adhesion formation. Ann NY Acad Sci. 2008;1144:116-126.

  51. 51.

    Kluger Y, Weinbroum A, Ben-Avraham R, Galili Y, Klausner J, Rabau M. Reduction in formation of peritoneal adhesions by methylene blue in rats: a dose response study. Eur J Surg. 2000;166(7):568-571.

  52. 52.

    Gul A, Kotan C, Dilek I, Gul T, Tas A, Berktas M. Effects of methylene blue, indigo carmine solution and autologous erythrocyte suspension on formation of adhesions after injection into rats. J Reprod Fertil. 2000;120(2):225-229.

  53. 53.

    Saed GM, Abu-Soud HM, Diamond MP. Role of nitric oxide in apoptosis of human peritoneal and adhesion fibroblasts after hypoxia. Fertil Steril. 2004;82(suppl 3):1198-1205.

  54. 54.

    Fletcher NM, Jiang ZL, Diamond MP, Abu-Soud HM, Saed GM. Hypoxia-generated superoxide induces the development of the adhesion phenotype. Free Radic Biol Med. 2008;45(4):530-536.

  55. 55.

    Jiang ZL, Fletcher NM, Diamond MP, Abu-Soud HM, Saed GM. S-nitrosylation of caspase-3 is the mechanism by which adhesion fibroblasts manifest lower apoptosis. Wound Repair Regen. 2009; 17(2):224-229.

  56. 56.

    Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999;353(9163):1476-1480.

  57. 57.

    Gonzalez-Quintero VH, Cruz-Pachano FE. Preventing adhesions in obstetric and gynecologic surgical procedures. Rev Obstet Gynecol. 2009;2(1):38-45.

  58. 58.

    Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol. 1993;82(2):213-215.

  59. 59.

    Bulletti C, Polli V, Negrini V, Giacomucci E, Flamigni C. Adhesion formation after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1996;3(4):533-536.

  60. 60.

    Brill AI, Nezhat F, Nezhat CH, Nezhat C. The incidence of adhesions after prior laparotomy: a laparoscopic appraisal. Obstet Gynecol. 1995;85(2):269-272.

  61. 61.

    Ashrafinia M, Vazirichimeh Z, Dastjerdi MV, Moiini A. Adhesion Formation in Patients with Previous Laparotomies. J Am Assoc Gynecol Laparosc. 1996;3(4 suppl):S2.

  62. 62.

    Leuwen V. Ann de. Gynec. 1904;2.s., i,:577-580.

  63. 63.

    Mason NR. The end results of caesarean section. Boston Med Surg J. 1911;CLXIV:889-891.

  64. 64.

    Juntunen K, Makarainen L, Kirkinen P. Outcome after a high number (4-10) of repeated caesarean sections. BJOG. 2004;111(6):561-563.

  65. 65.

    Diamond MP, Hershlag A. Adhesion formation/reformation. Prog Clin Biol Res. 1990;358:23-33.

  66. 66.

    Miller G, Boman J, Shrier I, Gordon PH. Etiology of small bowel obstruction. Am J Surg. 2000;180(1):33-36.

  67. 67.

    Monk BJ, Berman ML, Montz FJ. Adhesions after extensive gynecologic surgery: clinical significance, etiology, and prevention. Am J Obstet Gynecol. 1994;170(5 Pt 1):1396-1403.

  68. 68.

    Strieker B, Blanco J, Fox HE. The gynecologic contribution to intestinal obstruction in females. J Am Coll Surg. 1994;178(6):617-620.

  69. 69.

    Fevang BT, Fevang J, Lie SA, Soreide O, Svanes K, Viste A. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg. 2004;240(2):193-201.

  70. 70.

    Makoha FW, Fathuddien MA, Felimban HM. Choice of abdominal incision and risk of trauma to the urinary bladder and bowel in multiple cesarean sections. Eur J Obstet Gynecol Reprod Biol. 2006;125(l):50-53.

  71. 71.

    Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107(6):1226-1232.

  72. 72.

    Swank DJ, Van Erp WF, Repelaer Van Driel OJ, Hop WC, Bonjer HJ, Jeekel H. A prospective analysis of predictive factors on the results of laparoscopic adhesiolysis in patients with chronic abdominal pain. Surg Laparosc Endosc Percutan Tech. 2003;13(2):88-94.

  73. 73.

    Nisenblat V, Barak S, Griness OB, Degani S, Ohel G, Gonen R. Maternal complications associated with multiple cesarean deliveries. Obstet Gynecol. 2006;108(1):21-26.

  74. 74.

    Phipps MG, Watabe B, Clemons JL, Weitzen S, Myers DL. Risk factors for bladder injury during cesarean delivery. Obstet Gynecol. 2005;105(1):156-160.

  75. 75.

    Sobande A, Eskandar M. Multiple repeat caesarean sections: complications and outcomes. J Obstet Gynaecol Can. 2006; 28(3): 193-197.

  76. 76.

    Rahman MS, Gasem T, Al Suleiman SA, Al Jama FE, Burshaid S, Rahman J. Bladder injuries during cesarean section in a University Hospital: a 25-year review. Arch Gynecol Obstet. 2009; 279(3):349-352.

  77. 77.

    Kulenthran A, Sivanesaratnam V. Recurrent uterine myomata in three sisters—an uncommon occurrence. Int J Gynaecol Obstet. 1988;27(2):289-291.

  78. 78.

    Eisenkop SM, Richman R, Platt LD, Paul RH. Urinary tract injury during cesarean section. Obstet Gynecol. 1982;60(5):591-596.

  79. 79.

    Wang L, Merkur H, Hardas G, Soo S, Lujic S. Laparoscopic hysterectomy in the presence of previous caesarean section: a review of one hundred forty-one cases in the Sydney West Advanced Pelvic Surgery Unit. J Minim Invasive Gynecol. 2010;17(2):186-191.

  80. 80.

    Khashoggi TY. Higher order multiple repeat cesarean sections: maternal and fetal outcome. Ann Saudi Med. 2003;23(5):278-282.

  81. 81.

    Rashid M, Rashid RS. Higher order repeat caesarean sections: how safe are five or more? BJOG. 2004;111(10):1090-1094.

  82. 82.

    Shellhaas CS, Gilbert S, Landon MB, et al. The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol. 2009;114(2 Pt 1):224-229.

  83. 83.

    Kadanali S, Erten O, Kucukozkan T. Pelvic and periaortic pertioneal closure or non-closure at lymphadenectomy in ovarian cancer: effects on morbidity and adhesion formation. Eur J Surg Oncol. 1996;22(3):282-285.

  84. 84.

    Hugh TB, Nankivell C, Meagher AP, Li B. Is closure of the peritoneal layer necessary in the repair of midline surgical abdominal wounds? World J Surg. 1990;14(2):231-233; discussion 233-234.

  85. 85.

    Pearl ML, Rayburn WF. Choosing abdominal incision and closure techniques: a review. J Reprod Med. 2004;49(8):662-670.

  86. 86.

    Kingdom. RCoOaGU. Peritoneal closure. Guideline. 2002;15:1-7.

  87. 87.

    Bamigboye AA, Hofmeyr GJ. Closure versus non-closure of the peritoneum at caesarean section. Cochrane Database Syst Rev. 2003(4):CD000163.

  88. 88.

    Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005;193(5):1607-1617.

  89. 89.

    Malvasi A, Tinelli A, Farine D, et al. Effects of visceral peritoneal closure on scar formation at cesarean delivery. Int J Gynaecol Obstet. 2009;105(2):131-135.

  90. 90.

    Stark M, Chavkin Y, Kupfersztain C, Guedj P, Finkel AR. Evaluation of combinations of procedures in cesarean section. Int J Gynaecol Obstet. 1995;48(3):273-276.

  91. 91.

    Joura EA, Nather A, Hohlagschwandtner M, Husslein P. Peritoneal closure and adhesions. Hum Reprod. 2002;17(1):249-250.

  92. 92.

    Zareian Z, Zareian P. Non-closure versus closure of peritoneum during cesarean section: a randomized study. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):267-269.

  93. 93.

    Weerawetwat W, Buranawanich S, Kanawong M. Closure vs nonclosure of the visceral and parietal peritoneum at cesarean delivery: 16 year study. J Med Assoc Thai. 2004;87(9):1007-1011.

  94. 94.

    Lyell DJ, Caughey AB, Hu E, Daniels K. Peritoneal closure at primary cesarean delivery and adhesions. Obstet Gynecol. 2005; 106(2):275-280.

  95. 95.

    Tulandi T, Hum HS, Gelfand MM. Closure of laparotomy incisions with or without peritoneal suturing and second-look laparoscopy. Am J Obstet Gynecol. 1988;158(3 Pt 1):536-537.

  96. 96.

    Blumenfeld YJ, Caughey AB, El-Sayed YY, Daniels K, Lyell DJ. Single- versus double-layer hysterotomy closure at primary caesarean delivery and bladder adhesions. BJOG. 2010;117(6):690-694.

  97. 97.

    Coleman MG, McLain AD, Moran BJ. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum. 2000;43(9):1297-1299.

  98. 98.

    Beck DE, Ferguson MA, Opelka FG, Fleshman JW, Gervaz P, Wexner SD. Effect of previous surgery on abdominal opening time. Dis Colon Rectum. 2000;43(12): 1749-1753.

  99. 99.

    Diamond MP, Daniell JF, Feste J, et al. Adhesion reformation and de novo adhesion formation after reproductive pelvic surgery. Fertil Steril. 1987;47(5):864-866.

  100. 100.

    Diamond MP, Decherney AH. Pathogenesis of adhesion formation/reformation: application to reproductive pelvic surgery. Microsurgery. 1987;8(2):103-107.

  101. 101.

    Lower AM, Hawthorn RJ, Ellis H, O’Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG. 2000;107(7):855-862.

  102. 102.

    Lower AM, Hawthorn RJ, Clark D, et al. Adhesion-related readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24 046 patients. Hum Reprod. 2004;19(8):1877-1885.

  103. 103.

    Greenberg M DK, Blumenfeld Y, Caughey A, Lyell D. Do adhesions at repeat cesarean delay delivery of the newborn? Am J Obstet Gynecol. 2011;204(1):S267-S268.

  104. 104.

    Rouse DJ, MacPherson C, Landon M, et al. Blood transfusion and cesarean delivery. Obstet Gynecol. 2006;108(4):891-897.

  105. 105.

    Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, doubleblind multicenter study. J Am Coll Surg. 1996;183(4):297-306.

  106. 106.

    Milingos S, Kallipolitis G, Loutradis D, et al. Adhesions: laparoscopic surgery versus laparotomy. Ann N Y Acad Sci. 2000;900:272-285.

  107. 107.

    Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Hum Reprod Update. 2001;7(6):567-576.

  108. 108.

    Lalos O. Risk factors for tubal infertility among infertile and fertile women. Eur J Obstet Gynecol Reprod Biol. 1988;29(2):129-136.

  109. 109.

    Collin SM, Marshall T, Filippi V. Caesarean section and subsequent fertility in sub-Saharan Africa. BJOG. 2006;113(3):276-283.

  110. 110.

    Jolly J, Walker J, Bhabra K. Subsequent obstetric performance related to primary mode of delivery. Br J Obstet Gynaecol. 1999;106(3):227-232.

  111. 111.

    Hemminki E. Impact of caesarean section on future pregnancy— a review of cohort studies. Paediatr Perinat Epidemiol. 1996; 10(4):366-379.

  112. 112.

    Mollison J, Porter M, Campbell D, Bhattacharya S. Primary mode of delivery and subsequent pregnancy. BJOG. 2005; 112(8):1061-1065.

  113. 113.

    LaSala AP, Berkeley AS. Primary cesarean section and subsequent fertility. Am J Obstet Gynecol. 1987;157(2):379-383.

  114. 114.

    Murphy DJ, Stirrat GM, Heron J. The relationship between Caesarean section and subfertility in a population-based sample of 14 541 pregnancies. Hum Reprod. 2002;17(7):1914-1917.

  115. 115.

    Saraswat L, Porter M, Bhattacharya S. Caesarean section and tubal infertility: is there an association? Reprod Biomed Online. 2008;17(2):259-264.

  116. 116.

    Wolf ME, Daling JR, Voigt LF. Prior cesarean delivery in women with secondary tubal infertility. Am J Public Health. 1990;80(11):1382-1383.

  117. 117.

    Mol F, van Mello NM, Mol BW, van der Veen F, Ankum WM, Hajenius PJ. Ectopic pregnancy and pelvic inflammatory disease: a renewed epidemic? Eur J Obstet Gynecol Reprod Biol. 2010;151(2):163-167.

  118. 118.

    Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996; 65(6): 1093-1099.

  119. 119.

    Clayton HB, Schieve LA, Peterson HB, Jamieson DJ, Reynolds MA, Wright VC. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol. 2006;107(3):595-604.

  120. 120.

    Parazzini F, Tozzi L, Ferraroni M, Bocciolone L, La Vecchia C, Fedele L. Risk factors for ectopic pregnancy: an Italian casecontrol study. Obstet Gynecol. 1992;80(5):821-826.

  121. 121.

    Karaer A, Avsar FA, Batioglu S. Risk factors for ectopic pregnancy: a case-control study. Aust N Z J Obstet Gynaecol. 2006;46(6):521-527.

  122. 122.

    Peters AA, Trimbos-Kemper GC, Admiraal C, Trimbos JB, Hermans J. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol. 1992;99(1):59-62.

  123. 123.

    Hammoud A, Gago LA, Diamond MP. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis? Fertil Steril. 2004;82(6):1483-1491.

  124. 124.

    Almeida EC, Nogueira AA, Candido dos Reis FJ, Rosa e Silva JC. Cesarean section as a cause of chronic pelvic pain. Int J Gynaecol Obstet. 2002;79(2): 101-104.

  125. 125.

    Deneux-Tharaux C, Carmona E, Bouvier-Colle MH, Breart G. Postpartum maternal mortality and cesarean delivery. Obstet Gynecol. 2006;108(3 Pt 1):541-548.

  126. 126.

    Menacker F, Declercq E, Macdorman MF. Cesarean delivery: background, trends, and epidemiology. Semin Perinatol. 2006; 30(5):235-241.

  127. 127.

    Imudia AN, Hobson DT, Awonuga AO, Diamond MP, Bahado-Singh RO. Determinants and complications of emergent cesarean hysterectomy: supracervical vs total hysterectomy. Am J Obstet Gynecol. 2010;203(3):e221-e225.

  128. 128.

    Scott JR. Avoiding labor problems during vaginal birth after cesarean delivery. Clin Obstet Gynecol. 1997;40(3):533-541

  129. 129.

    Sbarra M, Boyd M, Dardarian TS. Complications due to adhesion formation following cesarean sections: a review of deliveries in three cases. Fertil Steril. 2009;92(1):394.e313-e396.

  130. 130.

    Uygur D, Gun O, Kelekci S, Ozturk A, Ugur M, Mungan T. Multiple repeat caesarean section: is it safe? Eur J Obstet Gynecol Reprod Biol. 2005;119(2):171-175.

  131. 131.

    Esmon CT, Vigano-D’Angelo S, D’Angelo A, Comp PC. Anticoagulation proteins C and S.Adv Exp Med Biol. 1987;214:47-54.

  132. 132.

    Petersen CM. Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology. Dan Med Bull. 1993;40(4):409-446.

  133. 133.

    Wallmo L, Gyzander E, Karlsson K, Lindstedt G, Radberg T, Teger-Nilsson AC. alpha 2-Antiplasmin and alpha 2-macroglobulin—the main inhibitors of fibrinolysis—during the menstrual cycle, pregnancy, delivery, and treatment with oral contraceptives. Acta Obstet Gynecol Scand. 1982;61(5):417-422.

  134. 134.

    Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29(2):125-130.

  135. 135.

    Rehman KS, Yin S, Mayhew BA, Word RA, Rainey WE. Human myometrial adaptation to pregnancy: cDNA microarray gene expression profiling of myometrium from nonpregnant and pregnant women. Mol Hum Reprod. 2003;9(11):681-700.

  136. 136.

    Prochazkova J, Dhaifallah I, Mechurova A, et al. [Monitoring of endothelial activation markers during physiological pregnancy]. Ceska Gynekol. 2010;75(2):92-100.

  137. 137.

    Hahn L, Korsan-Bengtsen K. The coagulation system during caerean section. Coagulation, fibrinolysis and hormonal levels in peripheral and uterine venous blood during caesarean section. Acta Obstet Gynecol Scand. 1975;54(1):49-55.

  138. 138.

    Roh CR, Oh WJ, Yoon BK, Lee JH. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod. 2000;6(1):96-102.

  139. 139.

    Choi SJ, Oh S, Kim JH, Roh CR. Changes of nuclear factor kappa B (NF-kappaB), cyclooxygenase-2 (COX-2) and matrix metalloproteinase-9 (MMP-9) in human myometrium before and during term labor. Eur J Obstet Gynecol Reprod Biol. 2007; 132(2):182-188.

  140. 140.

    Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta. 2010;31(suppl):S66-S69.

  141. 141.

    Aris A, Benali S, Ouellet A, Moutquin JM, Leblanc S. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia. Placenta. 2009; 30(4):342-347.

  142. 142.

    Khan RN, Matharoo-Ball B, Shaw RW. Antioxidant enzyme expression, lipid peroxidation, and protein oxidation in human myometrium with parturition. Reprod Sci. 2010;17(1):78-84.

  143. 143.

    Shynlova O, Tsui P, Dorogin A, Chow M, Lye SJ. Expression and localization of alpha-smooth muscle and gamma-actins in the pregnant rat myometrium. Biol Reprod. 2005;73(4):773-780.

  144. 144.

    Mesa A, Jessurun C, Hernandez A, et al. Left ventricular diastolic function in normal human pregnancy. Circulation. 1999; 99(4):511-517.

  145. 145.

    Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol. 1979;86(5):364-370.

  146. 146.

    Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol. 1992;80(6):1000-1006.

  147. 147.

    Leibson RG, Likhnitzky II, Sax MG. Oxygen transport of the foetal and maternal blood during pregnancy. J Physiol. 1936; 87(2):97-112.

  148. 148.

    Schrinsky DC, Benson RC. Rupture of the pregnant uterus: a review. Obstet Gynecol Surv. 1978;33(4):217-232.

  149. 149.

    Vercellini P, Trespidi L, Zaina B, Vicentini S, Stellato G, Crosignani PG. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril. 2003;79(6):1390-1395.

  150. 150.

    Coddington CC, Grow DR, Ahmed MS, Toner JP, Cook E, Diamond MP. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril. 2009; 91(5):1909-1913.

  151. 151.

    Darwish AM, Nasr AM, El-Nashar DA. Evaluation of postmyomectomy uterine scar. J Clin Ultrasound. 2005;33(4):181-186.

  152. 152.

    Jastrow N, Chaillet N, Roberge S, Morency AM, Lacasse Y, Bujold E. Sonographic lower uterine segment thickness and risk of uterine scar defect: a systematic review. J Obstet Gynaecol Can. 2010;32(4):321-327.

  153. 153.

    Vikhareva Osser O, Valentin L. Risk factors for incomplete healing of the uterine incision after caesarean section. BJOG. 2010; 117(9):1119-1126.

  154. 154.

    Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186(l):l-9.

  155. 155.

    Portz DM, Elkins TE, White R, Warren J, Adadevoh S, Randolph J. Oxygen free radicals and pelvic adhesion formation: I. Blocking oxygen free radical toxicity to prevent adhesion formation in an endometriosis model. Int J Fertil. 1991; 36(1):39-42.

  156. 156.

    Salaris SC, Babbs CF, Voorhees WD, 3rd. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol. 1991;42(3):499-506.

  157. 157.

    Ozcelik B, Serin IS, Basbug M, Uludag S, Narin F, Tayyar M. Effect of melatonin in the prevention of post-operative adhesion formation in a rat uterine horn adhesion model. Hum Reprod. 2003;18(8):1703-1706.

  158. 158.

    Sharpe-Timms KL, Zimmer RL, Jolliff WJ, Wright JA, Nothnick WB, Curry TE. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril. 1998;69(5):916-923.

  159. 159.

    Gago LA, Saed GM, Wang RX, Kruger M, Diamond MP. Effects of oxidized regenerated cellulose on the expression of extracellular matrix and transforming growth factorbeta1 in human peritoneal fibroblasts and mesothelial cells. Am J Obstet Gynecol. 2003;189(6):1620-1625; discussion 1625-1626.

  160. 160.

    Tarhan OR, Eroglu A, Cetin R, A YN, Bulbul M, Altuntas YR. Effects of seprafilm on peritoneal fibrinolytic system. ANZ J Surg. 2005;75(8):690-692.

  161. 161.

    Vrijland WW, Tseng LN, Eijkman HJ, et al. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg. 2002;235(2):193-199.

  162. 162.

    Reddy S, Santanam N, Reddy PP, Rock JA, Murphy AA, Parthasarathy S. Interaction of Interceed oxidized regenerated cellulose with macrophages: a potential mechanism by which Interceed may prevent adhesions. Am J Obstet Gynecol. 1997; 177(6):1315-1320; discussion 1320-1311.

  163. 163.

    Kim TH, Kim JS, Lee HH, Nam KH, Lee KH, Lee JJ. Prevention of vesicouterine adhesions after cesarean with Interceed [abstract]. Korean Soc Fetal Med. 2006;2:194.

Download references

Author information

Correspondence to Michael P. Diamond MD, FACOG.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Awonuga, A.O., Fletcher, N.M., Saed, G.M. et al. Postoperative Adhesion Development Following Cesarean and Open Intra-Abdominal Gynecological Operations. Reprod. Sci. 18, 1166–1185 (2011). https://doi.org/10.1177/1933719111414206

Download citation

Keywords

  • adhesions
  • cesarean
  • gynecological operations